These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 199395)

  • 21. Metabolic aberrations in gout.
    Seegmiller JE
    Clin Orthop Relat Res; 1970; 71():87-98. PubMed ID: 5270558
    [No Abstract]   [Full Text] [Related]  

  • 22. The glycogen storage diseases.
    Drash A; Field J
    Dis Mon; 1971 Oct; ():3-40. PubMed ID: 4255992
    [No Abstract]   [Full Text] [Related]  

  • 23. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human purine metabolism: some recent advances and relationships with immunodeficiency.
    Nuki G
    Ann Rheum Dis; 1983 Aug; 42 Suppl 1(Suppl 1):8-11. PubMed ID: 6311120
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular biology of phosphoribosyl pyrophosphate synthetase super-or hyperactivity].
    Iizasa T
    Nihon Rinsho; 1991 May; 49(5):1030-5. PubMed ID: 1648631
    [No Abstract]   [Full Text] [Related]  

  • 26. Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
    Boyle JA; Seegmiller JE
    Mod Trends Rheumatol; 1971; 2():299-322. PubMed ID: 4949589
    [No Abstract]   [Full Text] [Related]  

  • 27. Transfer of resistance to selective conditions from fibroblasts with mutant feedback-resistant phosphoribosylpyrophosphate synthetase to normal cells. A form of metabolic cooperation.
    Zoref E; de Vries A; Sperling O
    Adv Exp Med Biol; 1977; 76A():80-4. PubMed ID: 193380
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of oxypurine and its clinical implication].
    Hisatome I; Kotake H; Mashiba H
    Nihon Rinsho; 1989 Dec; 48 Suppl():413-6. PubMed ID: 2560080
    [No Abstract]   [Full Text] [Related]  

  • 29. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodulation of enzyme activity.
    Sols A
    Curr Top Cell Regul; 1981; 19():77-101. PubMed ID: 6460594
    [No Abstract]   [Full Text] [Related]  

  • 31. Enzyme activities in human liver.
    Schmidt E; Schmidt FW
    Enzymol Biol Clin (Basel); 1970; 11(1):67-129. PubMed ID: 4905868
    [No Abstract]   [Full Text] [Related]  

  • 32. Overproduction of uric acid in primary gout.
    Yü TF; Balis ME; Yip LC
    Arthritis Rheum; 1975; 18(6 Suppl):695-8. PubMed ID: 173347
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Characterization of purine metabolism in cultured fibroblasts from a gouty family with feedback-resistant phosphoribosylpyrophosphate synthetase.
    Zoref E; Sperling O; De Vries A
    Isr J Med Sci; 1975 Nov; 11(11):1216. PubMed ID: 173692
    [No Abstract]   [Full Text] [Related]  

  • 34. Inherited disorders of purine metabolism--underlying molecular mechanisms.
    Gutensohn W
    Klin Wochenschr; 1984 Oct; 62(20):953-62. PubMed ID: 6209448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etiology of hyperuricemia.
    Bendersky G
    Ann Clin Lab Sci; 1975; 5(6):456-67. PubMed ID: 173236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Ciba Found Symp; 1977; (48):143-64. PubMed ID: 204460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutual regulation between erythrocyte 2,3 diphosphoglycerate (DPG) and phosphofructokinase: observations on enzyme deficient red cells].
    Tarui S; Ichihara K; Kono N
    Nihon Rinsho; 1973 Aug; 31(8):2429-34. PubMed ID: 4271914
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of de novo purine synthesis in human and rat tissue: role of oxidative pentose phosphate pathway activity and of ribose-5-phosphate and phosphoribosylpyrophosphate availability.
    Sperling O; Boer P; Lipstein B; Kupfer B; Brosh S; Zoref E; Bashkin P; de Vries A
    Adv Exp Med Biol; 1977; 76A():481-7. PubMed ID: 193377
    [No Abstract]   [Full Text] [Related]  

  • 39. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
    Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defects in enzyme regulation versus defects in enzyme synthesis as cause of metabolic disorders.
    Belfiore F
    Enzyme; 1980; 25(2):132-7. PubMed ID: 6929752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.